Search For "favipiravir"
Recently published data on Favipiravir as treatment for mild to moderate C
Updated : 2 years, 2 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More
SC issues notice to Centre on plea seeking CBI probe against pharmaceutica
Updated : 2 years, 3 months ago IST
New Delhi [India], October 29 (ANI): The Supreme Court on Thursday issued notice to the Central government on a plea seeking registration of an FIR by the Central Bureau of Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir al
Read More
High doses of favipiravir counter SARS-CoV-2 in hamsters, Hydroxychloroqui
Updated : 2 years, 3 months ago IST
Washington [US], October 10 (ANI): Researchers report that treatment with high doses of favipiravir, an antiviral drug that has been used to treat pandemic influenza in Japan, significantly reduced SARS-CoV-2 levels in the lungs, improved lung pathology, and reduced virus transmission by dir
Read More
Odisha government to start favipiravir therapy for COVID-19 patients in ho
Updated : 2 years, 4 months ago IST
Bhubaneswar (Odisha) [India], October 6 (ANI): The Odisha government has decided to start favipiravir therapy for COVID-19 patients getting treatment in home isolation.
Read More
SC adjourns for two weeks plea seeking CBI case against pharma firms
Updated : 2 years, 4 months ago IST
New Delhi [India], September 16 (ANI): The Supreme Court on Wednesday adjourned for two weeks hearing on a plea seeking registration of an FIR by the Central Bureau of Investigation (CBI) against ten Indian pharmaceutical firms for manufacturing and selling Remdesivir and Favipiravir, allege
Read More
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Updated : 2 years, 5 months ago IST
Hyderabad (Telangana) [India], Aug 19 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment of patients with mild to moderate COVID-19 disease.
Read More
Fusion Health Care launches COVID-19 drug Favipiravir and an immunity boos
Updated : 2 years, 5 months ago IST
Hyderabad (Telangana) [India], Aug 17 (ANI/BusinessWire India): Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.
Read More
Glenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 mil
Updated : 2 years, 5 months ago IST
Mumbai (Maharashtra) [India] Aug 15 (ANI/PRNewswire): Highlights for Q1 FY 2020-21
Read More
Lupin launches Favipiravir in India for COVID treatment at Rs 49 per table
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Read More
Sun Pharma launches Favipiravir in India for Rs 35 per tablet
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
Read More
Converge Biotech announces the launch of Vergiflu (Favipiravir 200 mg) in
Updated : 2 years, 6 months ago IST
Hyderabad (Telangana) [India] Aug 4 (ANI/BusinessWire India): Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More